ZYNTESA

View On IPO.GOV.UK

Dead

on 30 Apr 2010

Last Applicant/ Owned by

Affymax Pharma Limited

The Broadgate Tower, 3rd Floor, 20 Primrose Street, London

, , EC2A 2RS

Serial Number

UK00002546184 filed on 30^th Apr 2010

Registration Number

UK00002546184 registered on
27^th May 2011

Correspondent Information

Kilburn & Strode LLP

Lacon London, 84 Theobalds Road, Holborn

London,

WC1X 8NL

ZYNTESA

pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarcti Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke; but not including ophthalmic pharmaceutical preparations.

Mark Details

Serial Number

UK00002546184

Mark Type

Word

Kind of mark

Individual

ZYNTESA

Classification Information

Class [5]Pharmaceutical Products

Mark Details

Serial Number

Mark Type

Kind of mark

Class [5]
Pharmaceutical Products